AstraZeneca’s Yong Ben Joins BioAlta as Chief Medical Officer

Xconomy San Diego — 

BioAlta has named Yong Ben its chief medical officer. Ben comes to San Diego-based BioAlta from AstraZeneca (NYSE: AZN), where he most recently served as global clinical lead in immune-oncology. BioAlta is developing conditionally active biologic proteins (CABs), which deliver a therapeutic payload or spark an immune response in specific areas of the body.